RBC Bioscience

RBC Bioscience Intangible Assets

The Intangible Assets of RBC Bioscience (6848.TWO) as of Nov 6, 2026 is 12.87 M TWD. In the previous year, Intangible Assets was 3.14 M TWD — a change of 310.39% (higher).

Intangible Assets

12.87 MTWD

YoY

310.39%

Last updated:

Intangible Assets of RBC Bioscience is 2024 12.87 M TWD. Intangible Assets of RBC Bioscience was 2023 3.14 M TWD. It decreases by 310.39% higher compared to the previous year.

The RBC Bioscience Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2018
4.33 M TWD
Jan 1, 2019
3.96 M TWD
Jan 1, 2020
3.54 M TWD
Jan 1, 2021
3.17 M TWD
Jan 1, 2022
2.45 M TWD
Jan 1, 2023
3.14 M TWD
Jan 1, 2024
12.87 M TWD
The RBC Bioscience Intangible Assets history
YEARIntangible AssetsYoY
12.87 MTWD+310.39%
3.14 MTWD+27.88%
2.45 MTWD-22.59%
3.17 MTWD-10.43%
3.54 MTWD-10.66%
3.96 MTWD-8.55%
4.33 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Intangible Assets of RBC Bioscience is 12.87 M TWD in 2024.

Intangible Assets of RBC Bioscience changed from 3.14 M TWD to 12.87 M TWD, representing a 310.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — RBC Bioscience

All Key Metrics — RBC Bioscience